Skip to content
RDL Network logo
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review — Steve Deitelzweig (2019) | RDL Network